消息

The leadership of MBX Biosciences has undergone significant changes. Steve Hoerter, current Executive Chairman, has been appointed as the new Chairman and Chief Executive Officer, replacing Kent Hawryluk who will step down from his positions. Mr. Hoerter brings extensive experience in building and scaling commercial-stage biotechnology companies, h...

全文

As a leading global player in construction consultancy, Arcadis operates in over 30 countries, with reported gross revenues of €4.9 billion for 2025. The company is committed to accelerating a planet‑positive future by making sustainable project choices, combining digital and human innovation, and embracing future‑focused skills across various sect...

全文

Strategically, Renault is expanding vehicle R&D and software development in China, a move aimed at capturing the region’s electric‑vehicle and digital‑mobility momentum. New senior leaders overseeing legal, compliance, partnerships, and digital transformation will shape how the company allocates capital, structures joint ventures, and navigates sup...

全文

Fair‑value estimates have been trimmed from €40.04 to €38.74, and many price targets cluster around €34. This reflects a split view: some analysts see alignment between the stock and refreshed assumptions, while others flag execution risk. Adjustments to revenue growth, net‑profit margin, and future P/E, combined with a lower discount rate, underpi...

全文

A recent High Court ruling in London, which cleared Renault of a major diesel‑emissions liability, lifted a significant overhang. The ruling helped lift the share price by 2.06 % to €25.81, but the year‑to‑date decline remains at 29.02 %. Analysts now value the company at €38.74, driven by expectations of improved profitability and a re‑rated earni...

全文

Renault’s share price has fallen 32.6% over the past year, yet discounted‑cash‑flow modelling values the stock at roughly €50.36 per share, implying a 48.8 % undervaluation versus the current market price. The company trades at a P/S ratio of 0.1x, well below the auto‑industry average of 0.6x and peer group average of 0.5x, and scores five of six v...

全文

The shift towards fee‑based, capital‑light With Profits products and PruFund is changing the mix of earnings at M&G, with private markets, international clients, and cost transformation playing key roles in supporting fee‑related income. Key execution risks, including net inflows, international expansion, and cost targets, could challenge the margi...

全文

However, not all analysts share this optimistic view, as Goldman Sachs has downgraded M&G. This highlights the importance of considering both bullish and bearish perspectives when evaluating M&G's potential. The company's Fair Value is now set at approximately £3.09, with revenue growth declining by about 44.16%, but profit margin increasing to aro...

全文

M&G's updated analyst narrative features a revised Fair Value price target of approximately £3.09, compared to around £3.03 previously. This adjustment is part of broader market commentary that suggests valuation anchors and target changes are currently driving M&G's market framing. Several firms have lifted their valuation markers for M&G, with Mo...

全文

The Excess Returns model estimates an intrinsic value of approximately €23.48 per share, implying a 25.7% undervaluation relative to the current price. However, traditional multiples, such as the P/E ratio, suggest that Tikehau Capital is trading at a premium, with a tailored fair P/E ratio sitting at 19.0x and the current multiple being over three...

全文